Urolog. pro Praxi, 2010; 11(6): 319-322

Laparoscopic modified retroperitoneal lymph node dissection

MUDr.Marek Schmidt, FEBU, MUDr.Pavel Hanek, MUDr.Štěpán Veselý, Ph.D., MUDr.Pavel Dušek
Urologická klinika UK, 2. lékařské fakulty a Fakultní nemocnice v Motole, Praha

Retroperitoneal lymph node dissection (RPLND) is among the methods used in the treatment of non-seminoma testicular cancers. It

involves a complete or modified removal of the retroperitoneal lymph nodes, the site of the first metastases. Prior to the introduction

of chemotherapy, RPLND was the only treatment method following radical orchiectomy. Particularly due to the challenging nature and

numerous complications of classic open RPLND, adjuvant chemotherapy is the method of choice in non-seminoma testicular cancers.

The introduction of a modified and nerve-sparing technique has reduced the rate of complications; however, open RPLND still remains

a demanding surgical procedure. The laparoscopic technique of lymphadenectomy provides an excellent benefit in terms of intraoperative

morbidity, has a lower rate of intraoperative complications and significantly improves the postoperative course.

Keywords: laparoscopy, retroperitoneal lymph node dissection, testicular tumors

Published: December 14, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Schmidt M, Hanek P, Veselý Š, Dušek P. Laparoscopic modified retroperitoneal lymph node dissection. Urol. praxi. 2010;11(6):319-322.
Download citation

References

  1. Kawaciuk I. Nádory varlat. Urologie. Praha: Galen, 2009: 408-409.
  2. Tošovský V, Abrahámová J, et al. Kryptorchismus. Praha: Triton, 2004.
  3. Abrahámová J. Testicular tumours. Management and treatment. Acta Univ. Carolinae monogr. CXXXVIII. Praha, 1990.
  4. Lashley DB, Lowe BA. A rational approach to managing stage I nonseminomatous germ cell cancer. Urol Clin North Am 1998; 25(3): 405-423. Go to original source... Go to PubMed...
  5. Ondruš D, Goncalves F, Kausitz J, Maťoška J, Belan V. The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumours (NSGCTT). Neoplasma 1996; 43(3): 195-197. Go to PubMed...
  6. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, Horwich A, Laguna MP. Guidelines on Testicular Cancer in EAU Guidelines, 2009 Edition, Arnhem, 12-15.
  7. Hendry WF, Norman A, Nichols J, Dearnaley DP, Peckham MJ, Horwich A. Abdominal relapse in stage I nonseminomatous germ cell tumours of the testis managed by surveillance or with adjuvant chemotherapy. BJU Int 2000; 86(1): 89-93. Go to original source... Go to PubMed...
  8. Spermon JR, Roeleveld TA, van der Poel HG, Hulsbergenvan de Kaa CA, Ten Bokkel-Huinink WW, van de Vijver M, Witjes JA, Horenblas S. Comparison of surveillance and retroperitoneal lymph node dissection in stage I nonseminomatous germ cell tumours. Urology 2002; 59(6): 923-929. Go to original source... Go to PubMed...
  9. Foster RS, Roth BJ. Clinical stage I nonseminoma: surgery versus surveillance. Semin Oncol 1998; 25(2): 145-153.
  10. Fossa SD, Kleep O, Ous S, et al. Unilateral retroperitoneal lymph node dissection in patiens with nonseminomatous testicular tumor in clinical stage I. Eur Urol 1984; 10: 17-23. Go to original source... Go to PubMed...
  11. Artura HO, Paula AAP, Suarez R, et al. Can selective retroperitoneal lymphadenectomy be better than unilateral retroperitoneal lymphadenectomy? Inter Braz J Urol 2003; 29; 412-417. Go to original source... Go to PubMed...
  12. Janetschek G, Hobish A, Hotl L, et al. Retroperitoneal lymphadenectomy for clinical stage I nonseminomatous testicular tumor: laparoscopy versus open surgery and impact of learning curve. J Urol 1996; 156(1): 89-93. Go to original source... Go to PubMed...
  13. Heidenreich A, Albert P, Hartmann M, et al. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the german testicular cancer study group. J Urol 2003; 169: 1710-1714. Go to original source... Go to PubMed...
  14. Albqami N, Janetschek G. Laparoscopic retroperitoneal lymph-node dissection in the management of clinical stage I and II testicular cancer. J Endourol. 2005; 19(6): 683-692. Go to original source... Go to PubMed...
  15. Poulakis V, Skriapas K, de Vries R, Dillenburg W, Ferakis N, Witzsch U, Becht E. Quality of life after laparoscopic and open retroperitoneal lymph node dissection in clinical stage I nonseminomatous germ cell tumor: a comparison study. Urology. 2006; 68(1): 154-160. Epub 2006 Jul 3. Go to original source... Go to PubMed...
  16. Corvin S, Sturm W, Schlatter E, Anastasiadis A, Kuczyk M, Stenzl A. Laparoscopic retroperitoneal lymph-node dissection with the waterjet is technically feasible and safe in testis cancer patient. J Endourol. 2005; 19(7): 823-826. Go to original source... Go to PubMed...
  17. Maldonado-Valadez R, Schilling D, Anastasiadis AG, Sturm W, Stenzl A, Corvin S. Post-chemotherapy laparoscopic retroperitoneal lymph-node dissection in testis cancer patients. J Endourol. 2007; 21(12): 1501-1504. Go to original source... Go to PubMed...
  18. Permpongkosol S, Lima GC, Warlick CA, Allaf ME, Varkarakis IM, Bagga HS, Kohanim S, Kavoussi LR. Postchemotherapy laparoscopic retroperitoneal lymph node dissection: evaluation of complications. Urology. 2007; 69(2): 361-365. Go to original source... Go to PubMed...
  19. Abdel-Aziz KF, Anderson JK, Svatek R, Margulis V, Sagalowsky AI, Cadeddu JA. Laparoscopic and open retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testis tumors. J Endourol. 2006; 20(9): 627-631. Go to original source... Go to PubMed...
  20. Hamilton RJ, Finelli A. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ-cell tumors: current status. Urol Clin North Am. 2007; 34(2): 159-169. Go to original source... Go to PubMed...
  21. Correa JJ, Politis C, Rodriguez AR, Pow-Sang JM. Laparoscopic retroperitoneal lymph node dissection in the management of testis cancer. Cancer Control. 2007; 14(3): 258-264. Go to original source... Go to PubMed...
  22. Steiner H, Peschel R, Janetschek G, Höltl L, Berger AP, Bartsch G, Hobisch A. Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience. Urology. 2004; 63(3): 550-555. Go to original source... Go to PubMed...
  23. Winfield HN. Laparoscopic retroperitoneal lymphadenectomy for cancer of the testis. Urol. Clin North Am, 1998; 25: 469-478. Go to original source... Go to PubMed...
  24. Palese MA, Su LM, Kavoussi LR. Laparoscopic retroperitoneal lymph node dissection after chemotherapy. Urology, 2002; 60: 130-134. Go to original source... Go to PubMed...
  25. Link RE, Allaf ME, Pili R, Kavoussi LR. Modelling the cost of management options for stage I nonseminomatous germ cell tumors: a desicion tree analysis. J Clin Oncol. 2005; 23(24): 5762-5773. Go to original source... Go to PubMed...
  26. Janetschek G, Hobisch A, Hittmair A, Höltl L, Peschel R, Bartsch G. Laparoscopic retroperitoneal lymphadenectomy after chemotherapy for stage IIB nonseminomatous testicular carcinoma. J Urol. 1999; 161(2): 477-481. Go to original source... Go to PubMed...
  27. Schmidt M, Hanek P, Dušek P, Veselý Š. Laparoskopická modifikovaná retroperitoneální lymfadenektomie. Endoskopie 2009; 18(2): 94-97.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.